(Q39987017)

English

Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

0 references

author name string

Yunlan Du

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Xuping Li

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Dehua Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Xiaojie Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Shen Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Kaixing Huang

6

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Weidong Le

7

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

29 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Experimental Biology and Medicine

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

233

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

881-890

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Dynamic modeling of alpha-synuclein aggregation for the sporadic and genetic forms of Parkinson's disease

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Understanding the molecular causes of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Lewy bodies in Parkinson's disease: protectors or perpetrators?

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

The role of ubiquitin-protein ligases in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Ubiquitin-proteasome system and Parkinson's disease

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Proteasome inhibitor lactacystin disturbs the intracellular calcium homeostasis of dopamine neurons in ventral mesencephalic cultures

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Point source concentration of GDNF may explain failure of phase II clinical trial

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Brain-derived growth factor and glial cell line-derived growth factor use distinct intracellular signaling pathways to protect PD cybrids from H2O2-induced neuronal death

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Glial-derived neurotrophic factor (GDNF) prevents ethanol (EtOH) induced B92 glial cell death by both PI3K/AKT and MEK/ERK signaling pathways.

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1.

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

PAN-811 provides neuroprotection against glutamate toxicity by suppressing activation of JNK and p38 MAPK.

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Stepholidine protects against H2O2 neurotoxicity in rat cortical neurons by activation of Akt.

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Proteasome inhibition and Parkinson's disease modeling

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Unbiased morphological measurements show no neuronal loss in the substantia nigra in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

The ubiquitin-proteasome pathway and proteasome inhibitors

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Glial cell-derived neurotrophic factor protects against proteasome inhibition-induced dopamine neuron degeneration by suppression of endoplasmic reticulum stress and caspase-3 activation

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Different species of alpha-synuclein oligomers induce calcium influx and seeding.

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic.

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Mitogen-activated protein kinase pathway mediates peroxynitrite-induced apoptosis in human dopaminergic neuroblastoma SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

The complexity of p53 stabilization and activation

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Neuronal life and death: an essential role for the p53 family

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Involvement of c-Jun N-terminal kinase and caspase 3-like protease in DNA damage-induced, p53-mediated apoptosis of cultured mouse cerebellar granule neurons.

1 reference

https://api.crossref.org/works/10.3181%2F0712-RM-329

21 January 2018

Identifiers

10.3181/0712-RM-329

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39987017&oldid=1882043764"